James River Group Holdings, Inc.

What they do

James River operates through two reportable segments: Excess and Surplus (E&S) Lines and Specialty Admitted Insurance. E&S Lines writes commercial casualty and specialty coverage through wholesale brokers, while Specialty Admitted Insurance primarily writes fronting business where most of the risk is ceded to reinsurers. The company also maintains a corporate segment.

Revenue drivers

• Excess and Surplus Lines — Core segment accounting for $250.2 million of gross written premium in Q2 2026 (83% of total), with net written premium of $147.7 million; combined ratio of 92.8%.
• Specialty Admitted Insurance — Deliberately reduced fronting business; gross written premium fell 76% to $18.7 million in Q2 2026, with only $0.7 million net written premium retained.
• Net earned premium — Total net earned premium was $139.0 million in Q2 2026, down 9% year over year, driven by the decline in Specialty Admitted.

Recent performance

In Q2 2026, net income available to common shareholders was $4.4 million, up 59% from $2.8 million in Q2 2025, with diluted EPS of $0.10. Adjusted net operating income was $10.0 million, or $0.20 per diluted share. E&S combined ratio improved to 92.8%, and group premium retention rose to 55% from 47%. For full-year 2025, revenue was $687.6 million and net income was $47.4 million, reversing an $81.1 million loss in 2024. Tangible common equity per share was $9.01, up 1% from year-end 2025.

Strategy

Management is prioritizing disciplined capital deployment in E&S, leveraging strong submission and quote growth. It is deliberately reducing exposure to the low-retention fronting business in Specialty Admitted, cutting segment expenses (down 42% in H1 2026). Focus is on cautious risk selection, expense management, and operating efficiency through innovation. General and administrative expenses fell 9% in H1 2026.

Risks

• A.M. Best negative outlook — A prolonged negative outlook could lead to a downgrade below 'A-' (Excellent), materially harming new business writing.
• E&S market competition — The CEO cited a competitive E&S backdrop; continued pricing pressure could reduce returns.
• Reserve development — Pre-tax net adverse reserve development of $0.6 million in Q2 2026, though improved from $3.0 million in the prior year quarter.
• Dividend and equity concerns — Dividends per share fell from $0.16 in 2024 to $0.04 in 2025, and shareholder equity at $522.6 million (June 30, 2026) is thin relative to $4.77B in assets.

Outlook

Management sees attractive opportunities across targeted casualty and specialty divisions, with meaningful growth in submissions and quotes. The company remains focused on improving returns and efficiency, with continued deliberate reduction in Specialty Admitted. No specific numeric guidance was provided.